Nika Pharmaceuticals, Inc (NIKA) stock
NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.00 (0.00%)
Close on Oct 16, 2026Market cap $431.19MP/E –Yield –
Nika Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nika Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.14K. For fiscal 2025 it was -$79.65K. The highest annual figure on record is $33.72K in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$79.65K | – |
| FY2024 | Dec 31, 2024 | -$154.93K | – |
| FY2023 | Dec 31, 2023 | -$64.83K | -292.3% |
| FY2022 | Dec 31, 2022 | $33.72K | +129.2% |
| FY2021 | Dec 31, 2021 | $14.71K | – |
| FY2020 | Dec 31, 2020 | -$8.91K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.60K | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.36K | – |
| Q4 FY2025 | Dec 31, 2025 | -$38.86K | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.33K | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.52K | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.95K | – |
| Q4 FY2024 | Dec 31, 2024 | -$28.30K | – |
| Q1 FY2024 | Mar 31, 2024 | -$84.35K | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.31K | -148.6% |
| Q3 FY2023 | Sep 30, 2023 | -$10.14K | -229.4% |
| Q2 FY2023 | Jun 30, 2023 | -$27.81K | -262.2% |
| Q1 FY2023 | Mar 31, 2023 | -$19.57K | – |
| Q4 FY2022 | Dec 31, 2022 | $15.05K | -42.4% |
| Q3 FY2022 | Sep 30, 2022 | $7.84K | – |
| Q2 FY2022 | Jun 30, 2022 | $17.14K | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.32K | – |
| Q4 FY2021 | Dec 31, 2021 | $26.12K | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.70K | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.96K | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.75K | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.75K | – |
See a number that looks wrong?